- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.11. | Converge is ready for more M&A, Paradigm Capital reports | ||
| 14.11. | Pieces coming together for WELL Health Technologies, says Beacon | ||
| 14.11. | Xebec Adsorption gets a target raise from Beacon Securities | ||
| 13.11. | Continued M&A from Nova Leap Health, says Echelon | ||
| 13.11. | Knight Therapeutics scores top and bottom line beats, Paradigm reports | ||
| 13.11. | Baylin Technologies is still a pass, says Paradigm | ||
| 13.11. | Target drop for Enthusiast Gaming from Paradigm Capital | ||
| 13.11. | A failed clinical trial for Appili Therapeutics, iA Capital reports | ||
| 12.11. | Medical Facilities is a Buy, says iA Capital | ||
| 11.11. | Tonnes of upside to Greenbrook TMS, says Clarus | ||
| 11.11. | BlackBerry management has a credibility problem, this investor says | ||
| 11.11. | It's painful owning Peloton right now, this portfolio manager says | ||
| 11.11. | Look for a rebound in Dialogue Health Tech, says Laurentian Bank | ||
| 11.11. | Netflix's dominance in streaming is here to stay, this investor says | ||
| 10.11. | CareRx has more room to grow, says iA Capital | ||
| 10.11. | Nanalysis Scientific scores target raise from Research Capital | ||
| 10.11. | It's still a pass on Computer Modelling Group, says Echelon Capital | ||
| 10.11. | kneat.com has momentum behind it, says Eight Capital | ||
| 10.11. | Here's why CareRx is a Buy right now | ||
| 10.11. | Newly IPO'd D2L is my Top Pick, this portfolio manager says | ||
| 10.11. | Three good-looking cannabis stocks for your portfolio | ||
| 10.11. | Accelerating growth is in the cards for Kinaxis, says National Bank | ||
| 10.11. | Echelon drops its target on Think Research | ||
| 10.11. | Online betting company Rivalry gets launched by Eight Capital with a Buy rating | ||
| 09.11. | Uber Technologies: what's wrong with this picture? |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
